膝髋假体周围感染治疗效果可联合报告且至少随访一年可靠
该回顾性研究比较了792例膝与髋假体周围感染(PJI)的治疗结果,发现两者在总体生存率及不同手术方式分层下均无显著差异。生存率在治疗后初期下降最快,约1.09年后趋于平台,提示一年随访足以准确报告治疗失败。
要点
- 膝与髋PJI在总体生存率及手术方式分层下无显著差异。
- 治疗后生存率初期下降最快,约1.09年后趋于平台。
- 建议一年随访足以准确报告PJI治疗失败。
核心结论
- 膝与髋PJI的治疗结果无差异,可联合报告。
- 一年随访足以准确报告PJI治疗失败。
研究设计与样本
- 回顾性研究纳入2000至2017年792例膝与髋PJI,接受清创或二期翻修。
- 治疗失败基于Delphi方法标准定义。
主要发现
- 膝与髋PJI总体生存率无显著差异(P = .71)。
- 清创分层无显著差异(P = .39),二期翻修分层无显著差异(P = .59)。
- 多因素及倾向匹配敏感性分析均无关节间差异。
- 生存率在治疗后初期下降最显著,1.09年后趋于平台。
关键数值与推荐
- 治疗失败定义基于Delphi方法标准。
- 总体生存率比较P = .71,清创分层P = .39,二期翻修分层P = .59。
- 生存率平台出现于1.09年。
临床怎么用
- 膝与髋PJI治疗结果可合并报告,无需关节特异性报告。
- 至少随访一年即可准确评估PJI治疗失败。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although there is an increasing trend toward reporting the outcome of hip and knee arthroplasty separately, it remains unknown whether joint-specific reporting is necessary for periprosthetic joint infection (PJI) as sample sizes are already low, given its relatively rare occurrence. The aim of this study is to compare treatment outcomes of PJI occurring after knee and hip arthroplasty. Furthermore, we aim to establish the necessary follow-up time for an accurate reporting of PJI treatment outcomes. METHODS: A retrospective study of 792 cases of hip and knee PJI treated with irrigation and debridement or two-stage exchange arthroplasty from 2000 to 2017 was performed. Treatment failure was defined based on the Delphi method-based criteria. The Kaplan-Meier survivorship curves were generated, and a log-rank test was used to evaluate differences in survivorship. A multivariate Cox proportional hazards regression and a sensitivity analysis using propensity matching were performed. A two-piecewise linear regression model was used to examine the threshold effect of time after treatment on survival rates. RESULTS: There were no significant differences between hip and knee PJIs in overall survivorship (P = .71), or when stratified by irrigation and debridement (P = .39), or two-stage exchange arthroplasty (P = .59). There was also no difference by joint in the multivariate or sensitivity analysis. Survival rates had the most dramatic rates of decrease in the initial months after treatment of PJI but began to plateau after 1.09 years. CONCLUSION: This study reveals no difference in treatment outcomes between knee and hip PJIs. In addition, given the difficulty with obtaining follow-up, we suggest that one-year follow-up is sufficient for an accurate reporting of treatment failure.
引用
- Xu C, Tan TL, Li WT, et al. Reporting Outcomes of Treatment for Periprosthetic Joint Infection of the Knee and Hip Together With a Minimum 1-Year Follow-Up is Reliable. J Arthroplasty. 2020. PMID: 32229149. doi:10.1016/j.arth.2020.02.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。